Ibuprofen Zentiva 800 mg Filmdragerad tablett

País: Suecia

Idioma: sueco

Fuente: Läkemedelsverket (Medical Products Agency)

Descargar Ficha técnica (SPC)
05-08-2021

Ingredientes activos:

ibuprofen

Disponible desde:

Zentiva k.s.

Código ATC:

M01AE01

Designación común internacional (DCI):

ibuprofen

Dosis:

800 mg

formulario farmacéutico:

Filmdragerad tablett

Composición:

ibuprofen 800 mg Aktiv substans

tipo de receta:

Receptbelagt

Resumen del producto:

Förpacknings: Blister, 10 tabletter; Blister, 100 tabletter; Blister, 20 tabletter; Blister, 30 tabletter

Estado de Autorización:

Godkänd

Fecha de autorización:

2021-05-04

Ficha técnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Ibuprofen Zentiva 400 mg film-coated tablets
Ibuprofen Zentiva 600 mg film-coated tablets
Ibuprofen Zentiva 800 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each  400 mg film-coated tablet contains ibuprofen 400
mg.
Each  600 mg film-coated tablet contains ibuprofen 600
mg.
Each  800 mg film-coated tablet contains ibuprofen 800
mg.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
 400 mg film-coated tablet: white to off-white rounded
film-coated tablets with
diameter 12 mm.
 600 mg film-coated tablet: white to off-white oblong
(17 x 10 mm) film-coated
tablets.
 800 mg film-coated tablet: light yellow to beige oblong
(20 x 10 mm) film-coated
tablets.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
[ 400 mg, 600 mg and 800 mg film-coated tablets]
Rheumatic conditions such as arthritic diseases (e.g. rheumatoid
arthritis including juvenile
rheumatoid arthritis), non-articular rheumatic conditions, other
muscular and joint disorders, and soft
tissue injuries.
 400 mg and 600 mg is recommended for adults and
adolescents from 40 kg
bodyweight (over 12 years).
800 mg  is recommended for adults only (see section
4.2).
[400 mg film-coated tablets]
In addition,  400 mg is intended for short-term
symptomatic treatment of mild to
moderate pain, migraine, primary dysmenorrhea and/or fever.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The treatment should start with the lowest dose anticipated to be
effective, which can subsequently be
adjusted, depending on the therapeutic response and any undesirable
effects.
The maximum single dose should not exceed 800 mg of ibuprofen for
adults and 600 mg of ibuprofen
for adolescents.
Undesirable effects may be minimised by using the lowest effective
dose for the shortest duration
necessary to con
                                
                                Leer el documento completo
                                
                            

Documentos en otros idiomas

Información para el usuario Información para el usuario inglés 05-04-2023
Ficha técnica Ficha técnica inglés 05-04-2023
Informe de Evaluación Pública Informe de Evaluación Pública inglés 25-03-2021

Buscar alertas relacionadas con este producto